- Home
- ELTX vs PHD Comparison
ELTX vs PHD Comparison
Compare ELTX & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- PHD
- Stock Information
- Founded
- ELTX 2011
- PHD 2004
- Country
- ELTX United States
- PHD United States
- Employees
- ELTX N/A
- PHD N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- PHD Investment Managers
- Sector
- ELTX Health Care
- PHD Finance
- Exchange
- ELTX Nasdaq
- PHD Nasdaq
- Market Cap
- ELTX 121.7M
- PHD 117.7M
- IPO Year
- ELTX N/A
- PHD N/A
- Fundamental
- Price
- ELTX $4.76
- PHD $9.05
- Analyst Decision
- ELTX Strong Buy
- PHD
- Analyst Count
- ELTX 2
- PHD 0
- Target Price
- ELTX $9.50
- PHD N/A
- AVG Volume (30 Days)
- ELTX 45.3K
- PHD 67.7K
- Earning Date
- ELTX 05-14-2025
- PHD 01-01-0001
- Dividend Yield
- ELTX N/A
- PHD 11.43%
- EPS Growth
- ELTX N/A
- PHD N/A
- EPS
- ELTX N/A
- PHD 1.27
- Revenue
- ELTX N/A
- PHD N/A
- Revenue This Year
- ELTX N/A
- PHD N/A
- Revenue Next Year
- ELTX N/A
- PHD N/A
- P/E Ratio
- ELTX N/A
- PHD $7.60
- Revenue Growth
- ELTX N/A
- PHD N/A
- 52 Week Low
- ELTX $3.34
- PHD $8.30
- 52 Week High
- ELTX $11.45
- PHD $9.81
- Technical
- Relative Strength Index (RSI)
- ELTX 30.36
- PHD 42.49
- Support Level
- ELTX $4.61
- PHD $8.84
- Resistance Level
- ELTX $5.11
- PHD $9.20
- Average True Range (ATR)
- ELTX 0.69
- PHD 0.23
- MACD
- ELTX -0.07
- PHD 0.00
- Stochastic Oscillator
- ELTX 5.56
- PHD 64.52
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About PHD Pioneer Floating Rate Fund Inc.
Pioneer Floating Rate Trust is a diversified, closed-end fund. Its investment objective is to provide a high level of current income and seek the preservation of capital by investing predominantly in floating-rate loans.